New association schedules with Oxaliplatin, Topotecan and 5-FU in sensitive and 5-FU-resistant cell lines.

被引：0
|
作者：
Taron, M
Plasencia, C
Abad, A
Guillot, M
Martin, C
Font, A
Barnadas, A
Rosell, R
机构：
[1] Hosp Germans Trias & Pujol, Med Oncol Serv, Badalona 08916, Barcelona, Spain
[2] Hosp Germans Trias & Pujol, Mol Biol Lab, Badalona 08916, Barcelona, Spain
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S13 / S13
页数：1
相关论文
共 50 条
  • [1] Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery
    De Angelis, Paula M.
    Svendsrud, Debbie H.
    Kravik, Katherine L.
    Stokke, Trond
    MOLECULAR CANCER, 2006, 5 (1)
  • [2] Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery
    Paula M De Angelis
    Debbie H Svendsrud
    Katherine L Kravik
    Trond Stokke
    Molecular Cancer, 5
  • [3] Possibility of rescue for 5-FU-resistant gastric cancer by combination administration of 5-FU with CDHP
    Sasaki, E
    Tominaga, K
    Kuwamura, H
    Shiba, M
    Watanabe, T
    Fujiwara, Y
    Oshitani, N
    Higuchi, K
    Matsumoto, T
    Arakawa, T
    GASTROENTEROLOGY, 2003, 124 (04) : A555 - A555
  • [4] Protracted infusional 5-fluorouracil (5-FU) with bolus mitomycin in 5-FU-resistant colorectal cancer
    Chester, JD
    Dent, JT
    Wilson, G
    Ride, E
    Seymour, MT
    ANNALS OF ONCOLOGY, 2000, 11 (02) : 235 - 237
  • [5] Aspirin suppresses chemoresistance and enhances antitumor activity of 5-Fu in 5-Fu-resistant colorectal cancer by abolishing 5-Fu-induced NF-κB activation
    Jinbo Fu
    Yiming Xu
    Yushan Yang
    Yun Liu
    Lulu Ma
    Yiyao Zhang
    Scientific Reports, 9
  • [6] Factors predicting efficacy of oxaliplatin in combination with 5-fluorouracil (5-FU) ± folinic acid in a compassionate-use cohort of 481 5-FU-resistant advanced colorectal cancer patients
    M A Bensmaïne
    M Marty
    A de Gramont
    S Brienza
    F Lévi
    M Ducreux
    E François
    E Gamelin
    H Bleiberg
    E Cvitkovic
    British Journal of Cancer, 2001, 85 : 509 - 517
  • [7] Aspirin suppresses chemoresistance and enhances antitumor activity of 5-Fu in 5-Fu-resistant colorectal cancer by abolishing 5-Fu-induced NF-κB activation
    Fu, Jinbo
    Xu, Yiming
    Yang, Yushan
    Liu, Yun
    Ma, Lulu
    Zhang, Yiyao
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [8] Factors predicting efficacy of oxaliplatin in combination with 5-fluorouracil (5-FU) ± folinic acid in a compassionate-use cohort of 481 5-FU-resistant advanced colorectal cancer patients
    Bensmaïne, MA
    Marty, M
    de Gramont, A
    Brienza, S
    Lévi, F
    Ducreux, M
    François, E
    Gamelin, E
    Bleiberg, H
    Cvitkovic, E
    BRITISH JOURNAL OF CANCER, 2001, 85 (04) : 509 - 517
  • [9] Preoperative chemoradiotherapy with 5-fluorouracil (5-FU) or 5-FU/oxaliplatin (5FU/OX) for rectal cancer is a feasible treatment strategy in the elderly
    Dolinsky, C. M.
    Mahmoud, N. N.
    Mick, R.
    Sun, W.
    Whittington, R.
    Solin, L. J.
    Haller, D. G.
    O'Dwyer, P.
    Fry, R. D.
    Metz, J. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S308 - S308
  • [10] Effect of time interval between surgery and preoperative chemoradiotherapy with 5-fluorouracil (5-FU) or 5-FU/oxaliplatin (5FU/OX) for rectal cancer
    Dolinsky, CM
    Mahmoud, NN
    Mick, R
    Sun, W
    Whittington, RW
    Solin, LJ
    Haller, DG
    Fry, RD
    Metz, JM
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S277 - S277
12345